Eagle Biosciences will be at the American Society for Bone and Mineral Research annual meeting this weekend, September 20-23 in Orlando. ASBMR 2019 is taking place at the Orange County Convention Center.

We have booth #626 stop by and see us!

We are especially excited to highlight our Intact FGF23 CLEIA and Fluobolt kits from our line of Bone Metabolism assays.



The ASBMR Annual Meeting is the world’s largest and most diverse meeting in the bone, mineral and musculoskeletal research field, attracting more than 3,000 attendees from more than 70 countries, including clinicians and researchers, representing all career levels and specializing in a variety of disciplines.

Contact us to set up a meeting or for more information about our bone metabolism kits

We at Eagle Biosciences, Inc are Proud to Announce an Exclusive Partnership with Kyowa Medex Co., Ltd from Tokyo, Japan!


MedFrontier FGF-23 provides a simpler and quicker assay procedure that yields a broader dynamic range than it’s competitors 


About the NEW MedFrontier FGF23 ELISA Kit…

MedFrontier FGF-23 is a sandwich ELISA kit that measures only intact/active forms of FGF23. Manufactured by Kyowa Medex Co. of Tokyo, Japan, the MedFrontier FGF23 is the only kit of its kind. Studying intact FGF23 has shown to provide greater accuracy when researching the importance of this protein.

Dynamic Range 15-3000 pg/mL
Incubation Time ~2 hours
Sample Size 20 µL
Sample Type Serum

What is FGF23?

Fibroblastic Growth Factor 23 (FGF23) is a hormone that is secreted by osteoblasts with the bones. This protein works primarily with the kidneys to help regulate levels of phosphate within the bloodstream via signals for removal or reabsorbtion. The parathyroid and digestive system also aid in phosphates homeostasis within the body. The kidneys remove excess phosphate through waste, and reabsorbs it via the small intestines when needed.

Why Measure FGF23?

Phosphate plays a critical role in the formation and growth of bones in children and maintaining strength in adults. If there is an imbalance of FGF23 within the bloodstream, it can cause hyper- and hypophosphatemia. These conditions have been linked to Rickets, osteomalacia, and impaired renal function to name a few.


EagleBio’s FGF23 (C-terminal) ELISA: Product Highlights

Bone Metabolism Assays

Measuring Both Intact and C-Terminal Fragments with Versatility and High Sensitivity.

FGF-23 (C-Terminal) ELISA is for Research Use Only, Not to be used for diagnostic procedures.

Eagle Biosciences’ Bone Metabolism Line is a comprehensive portfolio of assays for detecting and monitoring numerous biomarkers for the regulation of bone and mineral homeostasis, assisting researchers in various fields of study. One unique kit offered in our Bone Metabolism Line is our FGF23 (C-Terminal) ELISA which offers highly sensitivity, versatility with use of multiple sample types with excellent stability, and valuable results in emerging areas of research. Our FGF23 (C-Terminal) ELISA assay provides incredible value and unique insights for research surrounding the investigation new biomarkers that could improve prediction of CKD progression, as well as the discovery of new drug targets.

Why Measure FGF23 with EagleBio’s Assay?

  • Highly Sensitive: clear differentiation even at low serum FGF23 levels
  • Multi-Matrix Samples: serum and plasma samples (EDTA, heparin, citrate)
  • Serum Based Standards and Controls: provides biologically reliable data
  • Small Sample Volume: only 50 µl of sample required
  • Simple Assay: easy protocol, all reagents are included, and easily adapted for automation

EagleBio’s FGF23 ELISA is the most specific kit in the market, uniquely

designed to detect both Intact and C-Terminal fragments.

Related Kits:


Bone Metabolism Assay Kits

Related News:

January 2015: Eagle Biosciences Introduces New FGF23 (C-Terminal) ELISA